Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Submitted by
admin
on April 15, 2017 - 9:27am
Source:
Fierce Pharma
News Tags:
PTC Therapeutics
Emflaza
drug launches
drug pricing
Duchenne Muscular Dystrophy
Headline:
Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Do Not Allow Advertisers to Use My Personal information
